Product
OSP:rTTHc Cholera Conjugate Vaccine Cohort B
1 clinical trial
1 indication
Indication
Cholera Vaccination ReactionClinical trial
A Phase I, Multicenter, Observer-Blinded, Randomized, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety and Immunogenicity of the OSP:rTTHc Cholera Conjugate Vaccine in 19 to 45 Years Old Healthy Korean ParticipantsStatus: Recruiting, Estimated PCD: 2023-07-31